Wrist-Worn Noninvasive Blood Pressure Monitor Patents 2026
Wrist-Worn Noninvasive Blood Pressure Monitor Patents
From PPG-based optical sensing to calibration-free pulse wave velocity methods, wrist-worn NIBP monitoring is one of the most actively contested frontiers in consumer health IP. This dataset spans filings from 2006 to 2026 across multiple sensing modalities and jurisdictions.
Cuffless Wrist BP Monitoring: Sensing Modalities and Core Challenges
Wrist-worn NIBP monitoring measures systolic and diastolic blood pressure from the radial artery without cuffs or invasive catheters. The field spans optical PPG, PTT/PWV time-delay methods using ECG+PPG fusion, micro-motion and tonometry-inspired mechanical sensing, and machine learning-enhanced calibration-free estimation, all applied to a wrist form factor.
The dataset reveals three developmental phases: an early phase (2006–2014) of foundational wrist-cuff oscillometric and SAW-based patents; a mid-stage phase (2015–2020) dominated by Apple’s multi-sensor wrist platform and Huma Therapeutics’ micro-motion cuffless system; and a recent phase (2021–2026) marked by deep learning self-calibration, ultrasound radial artery imaging, and dual-modal fusion architectures.
Motion artifact suppression and calibration-free absolute blood pressure measurement remain the central unsolved engineering problems, explicitly cited across multiple patents and literature studies. Claims of calibration-free absolute BP appear in Apple, Huma, and Sotera filings, but clinical validation literature consistently shows residual calibration dependency — a persistent gap between patent claims and clinical evidence.
In this dataset, Apple Inc. leads with 4 retrieved patent records spanning WO, EP, and US jurisdictions, followed by Huma Therapeutics with 5 retrieved records and Sotera Wireless with 3 active US grants. India is the fastest-growing filing jurisdiction in retrieved records, with entries from Sensio Enterprises, Graphic Era University, and individual inventors, reflecting an open and contested innovation landscape.
Filing Trends and Technology Cluster Distribution
Across three developmental phases spanning 2006 to 2026, the retrieved dataset shows increasing geographic diversification and algorithmic sophistication. Core sensing modality clusters — PPG optical, PTT/PWV, multi-modal ML fusion, and mechanical/acoustic — each carry distinct patent volumes and commercial trajectories.
Technology Cluster Patent Distribution in Retrieved Records
PPG-based optical sensing and PTT/PWV methods together account for the largest share of retrieved filings in this dataset, with multi-modal ML fusion representing the fastest-growing recent cluster.
↗ Click bars to exploreFiling Activity by Developmental Phase (Retrieved Records)
Filing activity in this dataset accelerated significantly in the recent phase (2021–2026), with the most technically sophisticated approaches — deep learning self-calibration and ultrasound radial artery imaging — concentrated in the most recent years.
↗ Click bars to exploreKey Use Cases: Hypertension, Smartwatch, Clinical, and Telehealth
Wrist-worn NIBP devices in this dataset address four principal application domains: home hypertension management, consumer smartwatch health platforms, clinical and hospital continuous monitoring, and remote telehealth. Each domain carries distinct validation requirements, regulatory standards, and form-factor constraints.
Hypertension Home Monitoring
Wrist oscillometric devices including Omron’s RS6, RS8, and RS3 were validated against ESH-IP2 protocols for home use. The Omron HEM-9601T NightView wrist device was validated in 50 hypertensive patients for nocturnal supine home BP monitoring. The InBodyWATCH cuffless wristwatch achieved a correlation of r=0.964 for SBP versus manual sphygmomanometry using a neural network model.
Home MonitoringConsumer Smartwatch Health Platforms
Apple Inc.’s multi-filing wrist BP portfolio (WO 2016, EP 2017, US 2017, US 2020) explicitly targets a multi-function smartwatch integrating BP alongside other health metrics, claiming absolute BP without prior calibration. Huawei Watch BP monitoring was validated in a 2022 clinical study assessing compliance with ANSI/AAMI/ISO 81060-2:2018 guidelines. The TMART Technologies wrist device was assessed for validity and acceptability in a 2019 mixed-methods study.
Consumer Digital HealthClinical and Hospital Monitoring
Sotera Wireless’s body-worn cNIBP system holds multiple active US patents from 2019 to 2022, targeting continuous ward-level monitoring using a Composite Method combining ECG, PPG, accelerometer, and pressure waveforms. GE Precision Healthcare’s wrist cuff system (2007, US) was designed for clinical environments with automatic algorithm adjustment. Hebei Medical University Third Hospital’s 2025 CN filing targets critical care via fusion of invasive and noninvasive BP data streams using a machine learning framework.
Clinical MonitoringRemote and Telehealth Applications
The telemedicine-based NIBP bedside monitor filed by Politeknik Kesehatan Kemenkes Surabaya (2024, ID) integrates IoT platforms for remote BP access. Low-cost wrist-worn IoT vital signs monitors using ESP-32 microcontrollers and cloud platforms appear in literature from 2021. These architectures enable out-of-clinic BP data streaming relevant to hypertension telehealth programs.
Telehealth / IoTKey Patent Assignees in Wrist-Worn NIBP Monitoring (Retrieved Records)
In this dataset, Apple Inc. and Huma Therapeutics Limited account for the highest individual filing volumes, with 4 and 5 retrieved records respectively. A meaningful tail of smaller assignees — including Sotera Wireless, Sensio Enterprises, LiveMetric, and academic institutions — is also present in retrieved records, indicating an open and contested landscape.
Top Assignees by Filing Count — Wrist-Worn NIBP (Dataset Snapshot)
↗ Click bars to exploreApple Inc.
Apple holds 4 retrieved patent records spanning WO (2016), EP (2017), and US (2017, 2020) in this dataset, all directed at a multi-function wrist-worn device integrating optical, electrical, and mechanical sensors for BP monitoring. The US 2020 grant (active) claims absolute BP without prior calibration and covers passive and active measurement modes. Three of 4 filings carry active legal status, indicating a sustained commercial IP position across multiple jurisdictions.
United StatesHuma Therapeutics Limited
Huma Therapeutics holds 5 retrieved patent records in this dataset spanning WO (2019), AU (2020, two records), IN (2020), and US (2021), all covering micro-motion-based cuffless wrist BP monitoring of the radial artery with an explicit claim of no calibration requirement. Notably, 3 of 5 filings are listed as inactive, suggesting IP strategy evolution. The WO 2019 filing was the foundational international application in this portfolio.
United KingdomNext-Generation Approaches in Wrist-Worn NIBP
The most recent filings in this dataset (2023–2026) point to four convergent technical directions: deep learning self-calibration, ultrasound radial artery imaging, dual-modal invasive/noninvasive neural network fusion, and tubeless wireless cuff pulse wave systems.
Deep Learning Self-Calibration (2024)
Graphic Era Deemed to Be University’s 2024 Indian wristband patent explicitly integrates a deep learning data processing unit for self-calibration, moving beyond static calibration models toward adaptive, user-specific recalibration. The device combines a PPG sensor with a pressure-sensitive sensor and is described as lightweight, water-resistant, and rechargeable. This approach directly targets the central unsolved challenge of calibration-free absolute BP measurement in cuffless wrist devices.
Ultrasound Radial Artery Imaging (2023)
Sensio Enterprises’ 2023 wristband system uses a CMUT or piezo ultrasound array to directly image the radial artery and measure arterial elasticity in real time, moving beyond inferring arterial properties from surface signals. A neural network combines data from wrist, arm, and chest sensors for beat-to-beat BP estimation. This architecture represents a shift from signal-proxy methods to direct subsurface vascular imaging from a wrist-worn device.
PPG Optical vs. PTT/PWV: Core Technical Dimensions
Click any row to explore further.
| Dimension | PPG-Based Optical Sensing | PTT / PWV Methods |
|---|---|---|
| Primary Signal | Blood volume pulse from radial artery via LED and photodetector | Time delay between proximal cardiac event (ECG R-wave) and distal wrist PPG |
| Calibration Requirement | Typically requires initial calibration measurement; subject-dependent transform applied (Aktiia Bracelet, 2021) | Historically requires periodic recalibration; calibration-free claims in Sotera Wireless (2020) and Northwestern University (2025) |
| Sensors Required | Single wrist-mounted LED/photodetector array; optionally combined with pressure sensor (Graphic Era, 2024) | Multi-sensor array: ECG + PPG + accelerometer, often requiring chest or arm sensor in addition to wrist (Sotera Wireless Composite Method) |
| Motion Artifact Sensitivity | High; explicit motion artifact compensation required (LiveMetric WO 2017; skin-like optoelectronic devices, 2020) | Moderate; accelerometer integration in Composite Method partially mitigates motion artifacts |
| Clinical Validation Examples | Aktiia Bracelet (ISO81060-2 extended, 2021); InBodyWATCH (r=0.964 SBP, 2020); Huawei Watch (ANSI/AAMI/ISO 81060-2:2018, 2022) | Sotera Wireless cNIBP (active US grants 2019–2022); Northwestern University (active US grant 2025) |
| Key Assignees (Dataset) | Apple Inc., Huma Therapeutics, Graphic Era University, Aktiia, InBodyWATCH | Sotera Wireless, Northwestern University, Holux Technology, Goldenberg (2008) |
| Form Factor | Single wrist device; wristband or smartwatch (Apple multi-function smartwatch, Huma wristband) | May require chest/arm ECG patch in addition to wrist sensor; body-worn multi-site configuration |
Frequently Asked Questions: Wrist-Worn Noninvasive Blood Pressure Monitors
The dataset identifies four main modality clusters: (1) PPG-based optical sensing using LED/photodetector arrays at the radial artery; (2) PTT/PWV time-delay methods using ECG+PPG fusion; (3) multi-modal sensor fusion with machine learning combining PPG, piezoelectric, ultrasound, ECG, and accelerometry; and (4) mechanical/acoustic sensing including SAW pressure sensors and UWB radar combined with ultrasound.
In this dataset, Huma Therapeutics Limited holds the highest count with 5 retrieved records, followed by Apple Inc. with 4 records and Sotera Wireless with 3 active US records. Sensio Enterprises and GE Precision Healthcare each have 2 retrieved records. A tail of smaller assignees, universities, and individual inventors is also present.
According to multiple patents and literature studies in this dataset, calibration-free absolute blood pressure measurement and motion artifact suppression are the central unsolved engineering problems. Clinical validation literature consistently shows residual calibration dependency even in devices that claim calibration-free operation, creating a gap between patent claims and clinical evidence.
Apple filed a multi-function wrist-worn device portfolio spanning WO (2016), EP (2017), and two US grants (2017, 2020). The filings cover multiple sensor modalities — optical, electrical, and mechanical — integrated in a smartwatch, with passive and active BP measurement modes. The US 2020 grant claims absolute BP without prior calibration and carries active legal status.
The dataset references ISO 81060-2:2018 (including an extended protocol used for the Aktiia Bracelet cuffless wrist device validation in 2021), ANSI/AAMI/ISO 81060-2:2018 (used in the 2022 Huawei Watch validation study), ESH-IP2 protocols (used for Omron RS6, RS8, RS3 home wrist device validation), and IEEE 1708-2014 as relevant standards for clinical acceptance of wrist-worn BP devices.
The most recent filings in this dataset include: deep learning self-calibration in a 2024 Indian wristband (Graphic Era University); CMUT/piezo ultrasound array imaging of the radial artery in a 2023 Indian/WO filing (Sensio Enterprises); dual-modal invasive/noninvasive neural network fusion in a 2025 Chinese hospital filing (Hebei Medical University Third Hospital); tubeless wireless cuff pulse wave examination in a 2026 German filing (Fukuda Denshi); and calibration-free PWV using spatially separated wearable sensors in a 2025 active US academic patent (Northwestern University).
Data and insights on this page are based on a limited patent and literature dataset and are for reference only. Figures may not represent the complete technology landscape.